Bizarre Patents
Safety System For Remove a Rider From a Vehicle by Deploying a Parachute
Methods and apparatus for reducing the velocity of a rider in or on an open cockpit vehicle when the rider is thrown from the vehicle.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8119625 | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof Disclosed is an agent comprising a benzothiophene alkyl ether derivative represented by the general formula below or a salt thereof: wherein R1 and R2 independently represent at least one group selected ... | 02/21/2012 |
| 8067406 | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof An alkyl ether derivative represented by the following general formula [1] or its salt: wherein R1 and R2 represent each a substituent such as hydrogen, halogeno or alkyl; R3 represents alky... | 11/29/2011 |
| 8026232 | Benzothiophene oxide derivative and salt thereof Disclosed is a benzothiophene oxide derivative represented by the general formula (wherein R1 and R2 are the same or different and each represents one or more groups selected from a hydrogen atom, a halogen atom, an alkyl group, an aryl group, ... | 09/27/2011 |
| 7973030 | Benzothiazepine and benzothiepine compounds A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary s... | 07/05/2011 |
| 7855193 | S1P receptor modulating compounds and use thereof The present invention relates to compounds of the general formula (I) that have activity as S1P receptor modulating agents and the use of such compounds to treat diseases associated with inappropriate S1P receptor activity. The compounds may be used as immunomodulat... | 12/21/2010 |
| 7579340 | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use. ... | 08/25/2009 |
| 7456164 | 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstitut... | 11/25/2008 |
| 7342043 | Medicinal compositions improving brain function and method for improving brain function An alkyl ether derivative represented by the formula: wherein R1, R2, R3, R4, m and n are as defined in the specification, or salts thereof exhibits synergistically improved anti-... | 03/11/2008 |
| 7288538 | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use. ... | 10/30/2007 |
| 7214701 | Active substance combinations having insecticidal and acaricdal properties The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) ... | 05/08/2007 |
| 7132414 | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: in which R1 represents a radical —NHCOR4 or —N(R5)—Y—... | 11/07/2006 |
| 7087594 | Alkyl ether derivatives or salts thereof An alkyl ether represented by the general formula: or its salt. This compound has activity to protect neurons, activity to accelerate nerve regeneration and activity to accelerate neurite extension and hence is u... | 08/08/2006 |
| 6872717 | Pharmacological uses of azetidine derivatives A method of treating or preventing obesity, this method comprising administering to a patient in need of such treatment an effective amount of a compound of formula in which R, R3 and R4 are as de... | 03/29/2005 |
| 6864276 | Active substance combinations having insecticidal and acaricidal properties The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G ... | 03/08/2005 |
| 6858603 | Acetindine derivatives, their preparation and medicaments containing them Disclosed are azetidine derivatives of formula: their optical isomers, their salts, their preparation and medicaments containing them. ... | 02/22/2005 |
| 6846817 | Nicotine receptor ligands The invention provides nicotine receptor agonists of formula I: wherein R1, x, y, and n have any of the values given in the specification, or a pharmaceutically acceptable salt thereof, as well as pharmaceut... | 01/25/2005 |
| 6750213 | Estrogen receptor modulators The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a v... | 06/15/2004 |
| 6734176 | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: in which R1 represents a radical —NHCOR4 or —N(R5)—Y—R6 | 05/11/2004 |
| 6638972 | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor. ##STR1##... | 10/28/2003 |
| 6566356 | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: ##STR1## in which R1 represents a radical --NHCOR4 or --N(R5)--Y--R6, Y is CO or SO2 | 05/20/2003 |
| 6555569 | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection A pharmaceutical composition containing a glycogen phosphorylase inhibitor of Formula I or IA as defined herein is administered to a mammal to treat infection. ##STR1## ##STR2##... | 04/29/2003 |
| 6518264 | Azetidine derivatives, their preparation and medicaments containing them Disclosed are azetidine derivatives of formula: ##STR1## their optical isomers, their salts, their preparation and medicaments containing them.... | 02/11/2003 |
| 6489354 | 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity The present invention is directed to pyrrolidine compounds of the formula I: ##STR1## (wherein R1, R2, R3, R4c, R4d, and R4f are defined herein) which are useful as modulators of chemokine ... | 12/03/2002 |
| 6479479 | Azetidine derivatives, their preparation and pharmaceutical compositions containing them Compounds of formula: ##STR1## in which R represents a CR1 R2, C.dbd.C(R5)SO2 R6 or C.dbd.C(R7)SO2 alk radical, their preparation and the pharmaceutical compositions containing t... | 11/12/2002 |
| 6355631 | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation The present invention relates to pharmaceutical compositions containing, as an active ingredient, at least one compound of formula: ##STR1## in which R1 represents a radical --N(R4)R5, --N(R4)--CO--R5... | 03/12/2002 |
| 6051571 | Methods for treating medical dysfunctions and diseases using furan nitrone compounds Disclosed are methods for treating a patient with an acute central nervous system or cardiovascular disorder or a neurodegenerative, autoimmune or inflammatory disease using a pharmaceutical composition containing a pharmaceutically acceptable carrier and... | 04/18/2000 |
| 6043269 | cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of ... | 03/28/2000 |
| 5972964 | Aminomethylindans, -benzofurans and -benzothiophenes Compounds of formula I ##STR1## wherein R1.dbd.(cyclo)alk(en)yl, aralkyl, alkyl(oxy)carbonyl, CONH2, etc.; R2.dbd.H, (cyclo)alk(en)yl, aralkyl, etc.; R3-R5.dbd.H, halo, alkyl, alkoxy, etc.; R6,R7.dbd.H, alkyl; R6R7.dbd.atoms to complete a ring; ... | 10/26/1999 |
| 5929097 | Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors The present invention relates to the discovery of novel, low molecular weight, non-peptide inhibitors of matrix metalloproteinases (e.g. gelatinases, stromelysins and collagenases) and TNF- converting enzyme (TACE, tumor necrosis factor- con... | 07/27/1999 |
| 5919817 | Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of ... | 07/06/1999 |
| 5885983 | Inhibitors of microsomal triglyceride transfer protein and method Compounds are provided which inhibit microsomal triglyceride transfer protein and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases. The compounds have the structure ##STR1## wherein R1 to R6 | 03/23/1999 |
| 5869521 | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith Anti-pruritic pharmaceutical formulations containing kappa agonist compounds and methods of prevention or treatment of pruritus in a mammal with the anti-pruritic formulations.... | 02/09/1999 |
| 5834460 | Serine derivative A serine derivative represented by the general formula (I) ##STR1## (symbols in the formula represent the following meanings; X: a sulfur atom or an oxygen atom, Y: a nitrogen atom or CH, R1 and R2 : the same or different from each o... | 11/10/1998 |
| 5824674 | Brefeldin A derivatives and their utility in the treatment of cancer Provided are brefeldin A derivatives of the formula: ##STR1## wherein one of R1 and R2 is H and the other of R1 and R2 is a substituent group having 1 to 12 carbon atoms containing a basic nitrogen atom or ... | 10/20/1998 |
| 5817489 | Di-nitrogen heterocycle compositions Compositions comprising novel di-nitrogen heterocycle compounds containing at least one N-meta-substituted alkaryl group are prepared. The compounds of the present invention are useful as antibacterial and as other pharmaceutical agents and as intermediat... | 10/06/1998 |
| 5814643 | Sulfonamide fibrinogen receptor antagonists A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.... | 09/29/1998 |
| 5767116 | Bicyclic aromatic compounds as therapeutic agents Compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof in which A is methylene or --O--; B is methylene or --O--; and g is 0, 1, 2, 3 or 4; R1, R2, R3, R4, U, Q and T are defined in claim ... | 06/16/1998 |
| 5760023 | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith Anti-pruritic pharmaceutical formulations containing kappa agonist compounds and methods of prevention or treatment of pruritus in a mammal with the anti-pruritic formulations.... | 06/02/1998 |
| 5721253 | Fibrinogen receptor antagonists Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.... | 02/24/1998 |
| 5710148 | Corneal opacification inhibitory composition An ophthalmic preparation which comprises a fumagillol derivative represented by the general formula(I): ##STR1## wherein R1 is hydrogen; R2 is a halogen, N(O)m R5 R6, N+ R5... | 01/20/1998 |
